Clinical Trial Update: Epidemiological Study in FRONtoTemporal Dementia

View source ↗

Summary

The epidemiological study NCT05075187 on frontotemporal dementia sponsored by CENTOGENE GmbH Rostock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Snippet

Sponsor: CENTOGENE GmbH Rostock | Conditions: Frontotemporal Dementia | Status: COMPLETED